Johnson & Johnson Initiates Pivotal Global Phase 3 Clinical Trial of Janssen ’s COVID-19 Vaccine Candidate

NEW BRUNSWICK, N.J., September 23, 2020 – Johnson& Johnson (NYSE: JNJ) (the Company) today announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for its COVID-19 vaccine candidate,...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials